The blood saving potential of vortex versus roller pump with and without aprotinin
暂无分享,去创建一个
H. Aebert | D. Birnbaum | A. Wahba | A. Philip | M. Bauer | M. Kaiser | D. Birnbaum | MF Bauer | Matthias Bauer
[1] T. Dickinson,et al. A comparison of the benefits of roller pump versus constrained vortex pump in adult open-heart operations utilizing outcomes research. , 1994, The journal of extra-corporeal technology.
[2] H. Teufelsbauer,et al. Aprotinin does not decrease early graft patency after coronary artery bypass grafting despite reducing postoperative bleeding and use of donated blood. , 1994, The Journal of thoracic and cardiovascular surgery.
[3] P. Nurden,et al. Markers of platelet activation in coronary heart disease patients , 1994, European journal of clinical investigation.
[4] T. Sundt,et al. Renal dysfunction and intravascular coagulation with aprotinin and hypothermic circulatory arrest. , 1993, The Annals of thoracic surgery.
[5] F. Loop,et al. Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study. , 1992, The Annals of thoracic surgery.
[6] T. Masuzawa,et al. Influence of an impeller centrifugal pump on blood components in chronic animal experiments. , 1992, ASAIO journal.
[7] W. Butt,et al. Pump-induced haemolysis: is the constrained vortex pump better or worse than the roller pump? , 1992 .
[8] C. Yakut,et al. Cardiopulmonary Bypass Using Centrifugal Pump , 1992 .
[9] J. Driessen,et al. Comparison of the standard roller pump and a pulsatile centrifugal pump for extracorporeal circulation during routine coronary artery bypass grafting , 1991, Perfusion.
[10] J. Mathew,et al. Modulation of platelet surface adhesion receptors during cardiopulmonary bypass. , 1991, Anesthesiology.
[11] R. Hillman,et al. Platelet activation and aggregation during cardiopulmonary bypass. , 1991, Anesthesiology.
[12] G. Hafner,et al. Routine extracorporeal circulation with a centrifugal or roller pump. , 1991, ASAIO transactions.
[13] W. Prellwitz,et al. In-vitro assessment of centrifugal pumps for ventricular assist. , 1990, Artificial organs.
[14] W. van Oeveren,et al. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. , 1990, The Journal of thoracic and cardiovascular surgery.
[15] R. Guyton,et al. Hematologic derangements of cardiopulmonary bypass: a comparison of two perfusion systems. , 1990, The journal of extra-corporeal technology.
[16] K. M. Taylor,et al. EFFECT OF APROTININ ON NEED FOR BLOOD TRANSFUSION AFTER REPEAT OPEN-HEART SURGERY , 1987, The Lancet.
[17] J. Crowley,et al. In Vitro Comparison of the Blood Handling by the Constrained Vortex and Twin Roller Blood Pumps , 1987, The Journal of ExtraCorporeal Technology.
[18] E. Blackstone,et al. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. , 1981, The New England journal of medicine.
[19] M F Lynch,et al. Centrifugal blood pumping for open heart surgery. , 1978, Minnesota medicine.
[20] H. Huwer,et al. Is there a phase of hypercoagulability when aprotinin is used in cardiac surgery? , 1994, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[21] R. Prêtre,et al. Influence of aprotinin on early graft thrombosis in patients undergoing myocardial revascularization. , 1994, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[22] G. Hafner,et al. Reoperation and the centrifugal pump? , 1992, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.